eli lilly phase 3 trial retatrutide The numbers from Lilly's dropped this week and I haven't been able to stop thinking about them. Not only as a doctor but as a long-term GLP-1 user Seeking Differentiation Through a Triple

If someone starts a GLP-1 and: Doesn't strength train Doesn't prioritize protein Doesn't track body composition Doesn't monitor waist circumference Doesn't take progress photos Doesn't review training performance ...then yes, they're more likely to lose muscle than necessary

Doctors often base their recommendation on the patient's overall health, co-existing conditions, and potential side effect management

Some of our patients are on tiny doses if they dont need or dont tolerate higher doses, says Saunders

This approach maximizes accuracy during the critical early weeks when your body is still adapting to the peptide and precise dosing matters most

Steering clear of strong smells that may trigger nausea

Cell Death Differ 2012